Vector BioPharma raised €29M in a Series A round in Aug 2022. The company is based in Basel, Switzerland. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
This is the company's only recorded round.
